ACN
42
-16
BRK.B
42
2
CCL
50
3
DD
49
3
CVX
25
3
CRM
54
-3
APA
21
-4
AZO
63
11
PEG
46
5
AVGO
40
-14
NVDA
54
-6
MLM
61
-2
WU
30
6
CF
42
6
TSN
38
3
NAVI
38
2
CNP
67
4
FITB
50
2
C
40
4
VRTX
68
3
ACN
42
-16
BRK.B
42
2
CCL
50
3
DD
49
3
CVX
25
3
CRM
54
-3
APA
21
-4
AZO
63
11
PEG
46
5
AVGO
40
-14
NVDA
54
-6
MLM
61
-2
WU
30
6
CF
42
6
TSN
38
3
NAVI
38
2
CNP
67
4
FITB
50
2
C
40
4
VRTX
68
3
Financhill
Back

Albemarle Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
15

ALB
Albemarle

Last Price:
92.80
Seasonality Move:
0.91%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
15
Albemarle (ALB) is a Sell

Is Albemarle a Buy, Sell or Hold?

  • The current Albemarle [ALB] share price is $96.40. The Score for ALB is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ALB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALB Stock Price Chart

What is Albemarle's stock price today?

  • The Albemarle share price today is $96.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALB is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ALB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.55 Sell
Relative Strength Index (14 RSI): 24.44 Sell
Chaikin Money Flow: 2905021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.24 - 127.04) Sell
Bollinger Bands (100): (111.74 - 129.72) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

ALB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.18 Sell
20-day SMA: 112.68 Sell
50-day SMA: 119.16 Sell
200-day SMA: 131.36 Sell
8-day EMA: 100.9 Sell
20-day EMA: 109.5 Sell
50-day EMA: 117 Sell
200-day EMA: 137.79 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Albemarle Earnings Growth & ALB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.03 per share, an increase next quarter of $0.95 per share, a decrease this year of $18.83 per share, and an increase next year of $3.45 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Albemarle Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):